An Update in Drug-Induced Thrombotic Microangiopathy-Reference-Cited by-同舟云学术

An Update in Drug-Induced Thrombotic Microangiopathy

Published:2020-05-22 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Chatzikonstantinou Thomas,Gavriilaki Maria,Anagnostopoulos Achilles,Gavriilaki Eleni

Publisher

Frontiers Media SA

Subject

General Medicine

Reference87 articles.

1. Hypertension in hematologic malignancies and hematopoietic cell transplantation: an emerging issue with the introduction of novel treatments;Gavriilaki;Blood Rev,2019

2. Drug-induced thrombotic microangiopathy: a systematic review of published reports;Al-Nouri;Blood,2015

3. Drug-induced thrombotic microangiopathy: an updated systematic review, 2014-2018;Saleem;Am J Hematol,2018

4. Transplant-associated thrombotic microangiopathy is independently associated with ruxolitinib administration in patients with graft-versus-host-disease;Gavriilaki;EBMT,2020

5. Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA;Miller;Am J Kidney Dis,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Phenomenon of Thrombotic Microangiopathy in Cancer Patients;International Journal of Molecular Sciences;2024-08-21

2. Thrombotic Microangiopathies and the Kidney;Advances in Kidney Disease and Health;2024-05

3. Beyond Immunosuppression: The Intricate Relationship Between Tacrolimus and Microangiopathy;Cureus;2023-11-24

4. Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation;Bone Marrow Transplantation;2023-08-21

5. Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab;Scientific Reports;2023-06-21